Clinical Trial Update: Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

Phase I trial update on Cafusertib hydrochloride as monotherapy in Chinese patients with advanced solid tumors, focusing on initial safety and dosing in early d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cafusertib hydrochloride (cafusertib hydrochloride)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Neoplasms | Phase 1 | Status: UNKNOWN